MoneyWorks4Me

Epigral informs about outcome of board meeting

27 Jul 2026 Evaluate
Epigral has informed that the Board of Directors of the Company at its meeting held today i.e. Monday, 27th July, 2026 has discussed, approved, and taken on record the following matters: Approved Un-Audited Financial Results (Standalone & Consolidated) of the Company for the First Quarter ended on 30th June, 2026; and took on record ‘Limited Review Report’ thereon issued by S R B C & CO LLP, Statutory Auditors of the Company. A copy of the approved Un-Audited Financial Results along with Limited Review Report are enclosed. The meeting commenced at 12:00 Noon and concluded at 01:45 pm at the Registered Office of the Company situated at Ahmedabad.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
SRF 2507.70
BASF India 3692.20
Pidilite Inds. 1569.00
Tata Chemicals 610.30
Aarti Industries 504.45
View more..